Skip to main content

Regeneron Pharmaceuticals Evkeeza revenue

  • REGN · Nasdaq
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$955.47+0.45%Close 13 Nov 2026 · Market value $102.5B

Evkeeza revenue at Regeneron Pharmaceuticals came to $55.5M for the quarter to 30 Sep 2026, up 29.7% from a year earlier.

As Regeneron Pharmaceuticals reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.

By quarter

$24.0MDec 2023$24.8MMar 2024$30.4MJun 2024$32.4MSep 2024$38.1MDec 2024$30.9MMar 2025$41.2MJun 2025$42.8MSep 2025$47.3MDec 2025$45.7MMar 2026$53.3MJun 2026$55.5MSep 2026
Regeneron Pharmaceuticals Evkeeza revenue, every reported period
Period endingEvkeeza revenueChange on a yearFiled
30 Sep 2026$55.5Mup 29.7%30 Oct 2026
30 Jun 2026$53.3Mup 29.4%30 Jul 2026
31 Mar 2026$45.7Mup 47.9%29 Apr 2026
31 Dec 2025$47.3Mup 24.1%4 Feb 2026
30 Sep 2025$42.8Mup 32.1%28 Oct 2025
30 Jun 2025$41.2Mup 35.5%1 Aug 2025
31 Mar 2025$30.9Mup 24.6%29 Apr 2025
31 Dec 2024$38.1Mup 58.7%5 Feb 2025
30 Sep 2024$32.4Mup 69.6%31 Oct 2024
30 Jun 2024$30.4Mup 57.5%1 Aug 2024
31 Mar 2024$24.8Mup 66.4%2 May 2024
31 Dec 2023$24.0Mup 55.8%5 Feb 2024
30 Sep 2023$19.1Mup 40.4%2 Nov 2023
30 Jun 2023$19.3Mup 73.9%3 Aug 2023
31 Mar 2023$14.9Mup 75.3%4 May 2023
31 Dec 2022$15.4M—6 Feb 2023
30 Sep 2022$13.6Mup 106.1%3 Nov 2022
30 Jun 2022$11.1Mup 455.0%3 Aug 2022
31 Mar 2022$8.5Mup 1600.0%4 May 2022
30 Sep 2021$6.6M—4 Nov 2021
30 Jun 2021$2.0M—5 Aug 2021
31 Mar 2021$500,000—6 May 2021
31 Dec 2020$0—8 Feb 2021
30 Sep 2020$0—5 Nov 2020
30 Jun 2020$0—5 Aug 2020
31 Mar 2020$0—5 May 2020

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Regeneron Pharmaceuticals: Collaboration revenue · Net product sales · Libtayo revenue · Lynozyfic revenue · EYLEA HD And EYLEA revenue · EYLEA HD revenue · EYLEA revenue · Praluent revenue · financial statements

Every KPI and segment of REGN, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.